Zhong Yuan Bio-Technology Holdings Limited engages in the sale of plant-derived nervonic acid dietary supplements in China. It operates through four segments: Sales of Dietary Supplements; Research and Development Services; Royalties; and Event Organization. It also develops early detection kits for brain diseases and new drugs for neurological diseases; and technical supporting services. It sells its products under the Muzhiyuan-Neuro Enhancer brand. Zhong Yuan Bio-Technology Holdings Limited is based in Beijing, Hong Kong.
Frequently asked questions
What sector does Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) operate in?
Zhong Yuan Bio-Technology Holdings Limited belongs to the Consumer Staples sector and operates in the Packaged Foods industry.
What is Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) current stock price?
As of the latest data, Zhong Yuan Bio-Technology Holdings Limited stock price is $2.02, with a previous close of $2.02.
What is Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) current market capitalization?
Zhong Yuan Bio-Technology Holdings Limited market cap is approximately 35.75 million.
What is Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) Earnings Per Share (EPS)?
The trailing EPS is $0.02.
What is Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) Price-to-Earnings (P/E) ratio?
Zhong Yuan Bio-Technology Holdings Limited current P/E ratio is 101.
Does Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) pay dividends?
No. Zhong Yuan Bio-Technology Holdings Limited does not pay a dividend.
What is Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) beta (volatility) score?
Zhong Yuan Bio-Technology Holdings Limited has a beta of 4.082, indicating very high volatility compared to the market.